PubMed HealthSearch

PubMed · 6864866

Particle image-resolution test object.

Abstract

A blur definition and measurement technique for high-subject-contrast image resolution is proposed. A new test object utilizing the blur principle has been developed and feasibility tested. In developing this new test object, tests of various sizes and concentrations of small plastic particles in a gelatin base were performed. Optimum particle sizes and concentrations were selected for the popular clinical transducer frequencies. Test images were obtained with static and real-time transducers of various focal properties. In all cases the proposed test object clearly indicated the zone (focal zone) of optimum high-subject-contrast image resolution. The advantages of the proposed blur definition and measurement technique of high-subject-contrast image resolution include: test object simplicity, ease of performing and interpreting the measurement, usefulness for all types of real-time scanners, and the need for only one scan for both axial and lateral resolution information at all image depths.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Goldstein, W Clayman. 1983. Particle image-resolution test object.. https://doi.org/10.7863/jum.1983.2.5.195

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

An impact assessment of the European medical device regulations implementation - the current status quo.

BACKGROUND: This research aims to assess the current impact of the medical and in-vitro diagnostic devices regulations (MDR/IVDR) on the device industry in the EU, under the lens of postimplementation and the amending regulation, and in advance of the final transition to the IVDR/MDR in the future. RESEARCH DESIGN AND METHODS: A quantitative survey was administered to a diverse cohort of medical device enterprises, ranging from micro to large organizations. RESULTS: The survey indicates that the MDR/IVDR has harmed innovation, leading many manufacturers to seek initial device approval and launch elsewhere before in Europe. There is evidence that some manufacturers have rationalized their existing product portfolios and removed devices from the market as they stated they would in previous industry surveys. The MDR/IVDR has been shown to negatively impact manufacturers, with increased costs related to notified body (NB) fees, maintaining and updating documentation, recertification fees, and hiring additional staff. CONCLUSION: This study provides a current status of the effects of MDR/IVDR on manufacturers and finds that despite amending regulations and other interventions taken by the EU to mitigate regulatory burden, ensure product availability, and address stakeholder concerns, the EU is no longer the market of choice for new products.

Equipment and Supplies